Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 54.6 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 58.5 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 7.4 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 2.0 | BCD100624C013 | - | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 168 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 45 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 65.6 | pmol/sample |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 79.1 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 0.0 | BCD100624C001 | 62.6 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 0.5 | BCD100624C003 | 19.3 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 1.0 | BCD100624C007 | 238 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 2.0 | BCD100624C011 | 74.2 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 4.0 | BCD100624C015 | - | pmol/sample |
| LMFA01010014 | Myristic acid | C | 8.0 | BCD100624C019 | 153 | pmol/sample |
| LMFA01010014 | Myristic acid | C | 12.0 | BCD100624C023 | - | pmol/sample |
| LMFA01010014 | Myristic acid | C | 24.0 | BCD100624C027 | 78.5 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 63.4 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | 87.9 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 24.2 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 147 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 40.2 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 131 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 191 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 0.5 | BCD100624C004 | 87.8 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 1.0 | BCD100624C008 | - | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 2.0 | BCD100624C012 | 90 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 4.0 | BCD100624C016 | 40.3 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 8.0 | BCD100624C020 | 248 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 12.0 | BCD100624C024 | 66.6 | pmol/sample |
| LMFA01010014 | Myristic acid | 25OH-Chol | 24.0 | BCD100624C028 | 86.4 | pmol/sample |